Bortezomib
Takeda
['dlbcl', 'lymsm', 'kudos']
remodl-b shows a study design with randomization after cycle 1 (for molecular profiling in their study) works for frontline dlbcl. kudos to the study team. #lymsm #ash22
Statistician & #lymphoma researcher at Mayo Clinic. #lymsm. Working dad of 3.  Occasional gravel cyclist, love the woods.  Tweets mine.  He/him/his